Anti-tuberculosis drug development <i>via</i> targeting the cell envelope of <i>Mycobacterium tuberculosis</i>.

Anti-tuberculosis drug development via targeting the cell envelope of Mycobacterium tuberculosis.

Xu, Xinyue; Dong, Baoyu; Peng, Lijun; Gao, Chao; He, Zhiqun; Wang, Chuan; Zeng, Jumei.

Afiliação

Xu X; West China-PUMC CC Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
Dong B; West China-PUMC CC Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
Peng L; West China-PUMC CC Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
Gao C; State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.
He Z; Laboratory of Human Diseases and Immunotherapies, West China Hospital, Sichuan University, Chengdu, China.
Wang C; West China-PUMC CC Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
Zeng J; West China-PUMC CC Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.

Front Microbiol ; 13: 1056608, 2022.

Article em En | MEDLINE | ID: mdl-36620019